Previous 10 | Next 10 |
Findings of study published in PLOS One found a highly significant correlation between temperature and the rate of increase in COVID-19 An estimated one degree increase in temperature is associated with a 1% decrease in COVID-19 transmissions, and a one degree decrease i...
Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER) confirmed that a press release issued earlier today with respect to an earnings call by Aker ASA was issued by a company wholly unrelated to the Company. The press release was errantly issued by the newswire services u...
Gainers: Onconova Therapeutics (ONTX) +29%, Processa Pharmaceuticals (PCSA) +26%, AnPac Bio-Medical Science ANPC +25%, Oncolytics Biotech ONCY +22%, Cleveland BioLabs (CBLI) +15%.Losers: Interpace Biosciences IDXG -24%, AIkido Pharma AIKI...
AC Immune SA (ACIU) +112% as its vaccine generates potent anti-pTau antibody response in a phase 1b/2a study.RCM Technologies, Inc. (RCMT) +92%.Sundial Growers Inc. (SNDL) +48%.MicroVision, Inc. (MVIS) +44% after long range lidar update.Monopar Therapeutics (MNPR) +41% on poten...
Will These Penny Stocks Continue Showing Bullish Interest This Month? With November behind us, December is a new month to find penny stocks to watch. Although we are only a few days into the month, some penny stocks are already finding their stride. While searching for penny stocks ...
Akers Biosciences' ([[AKER]] +2.5%) proposed merger partner MyMD Pharmaceutical has been issued US Patent No. 10,835,523 B2, covering method of regulating tumor necrosis factor-alpha for cancers, autoimmune and other disorders associated with chronic inflammation, by USPTO. The patent is...
Patent protects methods of regulating TNF-α to treat cancers, autoimmune disorders, and other disorders associated with chronic inflammation Akers Biosciences, Inc. (Nasdaq: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (...
NEW YORK, NY / ACCESSWIRE / November 20, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: HD Supply Holdings, Inc. (NASDAQ:HDS) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its ...
WeissLaw LLP Reminds ALSK, EIGI, AKER, and TNAV Shareholders About Its Ongoing Investigations PR Newswire NEW YORK, Nov. 19, 2020 NEW YORK , Nov. 19, 2020 /PRNewswire/ -- If you own shares in any of the companies listed above and would lik...
MyMD Pharmaceuticals, Inc. ("MyMD") and Akers Biosciences, Inc. ("Akers") (NASDAQ: AKER) jointly announced a definitive merger agreement last week. The companies plan to hold a video conference for investors on Wednesday, November 18, 2020 at 4:15 p.m. ET to provide additional conte...
News, Short Squeeze, Breakout and More Instantly...
Akers Biosciences Inc. Company Name:
AKER Stock Symbol:
NASDAQ Market:
Akers Biosciences Inc. Website:
FORT WORTH, Texas, April 29, 2021 (GLOBE NEWSWIRE) -- Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) today announced the appointment of Karen Simon and Janet Pasque to its Board of Directors (the “Board”) effective...
Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol " MYMD " Upon Closing, the Combined Company will focus on developing and commercializing novel immunotherapy pipeline assets, including its lead molecule MYMD-1 ...
Akers Biosciences, Inc. (NASDAQ: AKER), today announced that its proposed merger partner MyMD Pharmaceuticals, Inc. (“MyMD”), a clinical stage pharmaceutical company committed to extending health lifespan and treating immune mediated illnesses, has reached an agreement...